Finance

Lists
300026:SHE
Tianjin Chase Sun Pharmaceutical Co Ltd
CNÂ¥3.40
+3.34%
(+0.11) 1D
Sep 8, 3:04:37 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300026...
Open
CNÂ¥3.29
High
CNÂ¥3.42
Low
CNÂ¥3.27
Mkt. cap
9.88B
Avg. vol.
79.67M
Volume
73.54M
Dividend
0.29%
Quarterly dividend
CNÂ¥0.00
Ex-dividend date
Jul 15, 2026
P/E ratio
569.51
52-wk high
CNÂ¥3.99
52-wk low
CNÂ¥2.82
EPS
CNÂ¥0.01
Shares outstanding
3.00B
No. of employees
5K
Open
CNÂ¥3.29
High
CNÂ¥3.42
Low
CNÂ¥3.27
Mkt. cap
9.88B
Avg. vol.
79.67M
Volume
73.54M
Dividend
0.29%
Quarterly dividend
CNÂ¥0.00
Ex-dividend date
Jul 15, 2026
P/E ratio
569.51
52-wk high
CNÂ¥3.99
52-wk low
CNÂ¥2.82
EPS
CNÂ¥0.01
Shares outstanding
3.00B
No. of employees
5K
About Tianjin Chase Sun Pharmaceutical Co Ltd
CEO-
Employees4.85K
Founded1996
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.35B
792.56M
1.13B
1.06B
Cost of goods sold
591.25M
210.74M
481.15M
459.97M
Cost of revenue
591.25M
210.74M
481.15M
459.97M
Research and development expenses
43.03M
59.53M
45.15M
40.87M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
563.09M
545.90M
487.36M
490.69M
Operating expense
649.03M
629.26M
557.39M
528.77M
Total operating expenses
1.24B
840.00M
1.04B
988.74M
Operating income
113.31M
-47.44M
91.69M
68.98M
Other non operating income
-20.37M
-8.94M
-2.84M
-13.48M
EBT including unusual items
31.89M
-58.55M
84.27M
23.16M
EBT excluding unusual items
90.70M
-61.38M
87.15M
57.20M
Income tax expense
24.58M
11.15M
15.65M
8.87M
Effective tax rate
77.09%
-19.04%
18.57%
38.30%
Other operating expenses
-635.90K
28.18M
10.63M
11.46M
Net income
2.13M
-62.27M
65.71M
12.37M
Net profit margin
0.16%
-7.86%
5.81%
1.17%
Earnings per share
-
-
-
-
Interest and investment income
2.96M
2.64M
2.22M
3.91M
Interest expense
-4.39M
-4.90M
-3.91M
-2.22M
Net interest expenses
-1.43M
-2.26M
-1.69M
1.69M
Depreciation and amortization charges
-
-
-
-
EBITDA
184.49M
20.83M
159.96M
137.62M
Gain or loss from assets sale
-1.89K
-702.54K
-
-11.04K
AI content may include mistakes. Learn more
Google apps